Dissecting the Parabrachial Nucleus’s Role in the Development and Maintenance of Neuropathic Pain
剖析臂旁核在神经病理性疼痛的发生和维持中的作用
基本信息
- 批准号:10710096
- 负责人:
- 金额:$ 8.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAbsence of pain sensationAddressAffectAfferent NeuronsAgonistAmygdaloid structureAnalgesicsBehaviorBehavioralBehavioral SymptomsBrainBrain regionCellsComplexCoupledDataData SetDevelopmentDiseaseEducational process of instructingElectrophysiology (science)EquilibriumFamilyFellowshipFluorescent in Situ HybridizationFrequenciesGeneral PopulationGenesGeneticGenetic TechniquesGlutamatesGoalsImmediate-Early GenesInjuryInstitutionInterneuronsKnock-outLabelLaboratoriesLearningLesionMaintenanceMeasuresMediatingMentorsMentorshipMessenger RNAMethodsMusNational Research Service AwardsNeurobiologyNeuronsNeuropeptide Y ReceptorNeuropeptidesNeurosciencesNociceptionNociceptorsNucleosomesOpioidOutputPainPathologicPatientsPeripheralPeripheral nerve injuryPharmacologyPhasePhysiologicalPopulationPositioning AttributePostdoctoral FellowPrincipal InvestigatorProteinsQuality of lifeReportingResearchResearch PersonnelRoleSignal TransductionSliceSocietiesSpinalSpinal CordSpinal cord posterior hornStimulusSystemTechniquesTechnologyTestingTherapeuticTissuesTrainingUnited StatesUniversitiesVertebral columnWorkWritingaspiratebehavior testbehavioral pharmacologychronic painchronic painful conditiondorsal hornexperiencehealingimprovedin vivoin vivo calcium imaginginflammatory painmouse modelnerve injuryneuralneuropeptide Yneuropeptide Y-Y1 receptorneurotransmissionnovel strategiesoptogeneticspain perceptionpainful neuropathyparabrachial nucleuspatch clamppostsynapticpresynapticreceptorsegregationsham surgerysingle-cell RNA sequencingskillssomatosensorytemporal measurementtenure tracktranscriptome sequencingtranscriptomicsvoltage clampwireless
项目摘要
Project Summary
Chronic pain conditions place significant burdens on patients, their families, and society by reducing quality of
life and creating enormous financial consequences that total more than 630 billion USD annually for the United
States of America alone. Neuropathic pain is a debilitating type of chronic pain that arises from a lesion or disease
affecting the somatosensory system. Neuropathic pain affects 7-8% of the general population yet is poorly
responsive to analgesic drugs, including opioids, thus, alternative therapeutics for treatment are desperately
needed. However, the underlying mechanisms of the development and maintenance of neuropathic pain are
poorly understood. It is hypothesized that neuropathic pain results from a loss of spinal cord dorsal horn inhibition
and/or a gain in dorsal horn excitation that allows the propagation of low threshold innocuous inputs to be
perceived as painful. Exactly how nerve injury disrupts this balance to generate a net pronociceptive tone,
however, remains unclear. Specific Aim 1 describes promising preliminary data within our laboratory that
implicates glutamatergic dorsal horn interneurons expressing the neuropeptide Y (NPY) Y1 receptor in both the
development and maintenance of neuropathic pain. First, selective ablation of neuropeptide Y1 receptor-
expressing interneurons (Y1-INs) with intrathecal NPY-saporin reduced the development of behavioral signs of
neuropathic pain. Second, intrathecal pharmacology and intraspinal chemogenetic techniques indicate that Y1-
INs are both necessary and sufficient for the behavioral manifestations of neuropathic pain. Lastly, both single
cell RNA-sequencing and fluorescence in situ hybridization data indicate that Y1-INs segregate into three distinct
dorsal horn interneuron subpopulations. Together, these observations form the premise for my central
hypothesis that nerve injury increases the excitability of Y1-INs, and this makes one or more subpopulations of
Y1-INs necessary for the behavioral symptoms of neuropathic pain. Specific Aim 2 will explore this hypothesis
via intraspinal pharmacology, behavioral testing, in vivo wireless optogenetics, intersectional Cre-lox
transgenics, and patch clamp electrophysiology. Together these methods will test which Y1-IN subpopulation(s)
is/are necessary for the behavioral signs of neuropathic pain. Further, these methods will assess changes in pre-
or postsynaptic excitatory and inhibitory activity to Y1-INs following nerve injury to uncover mechanistic changes
in the circuit that might lead to the development of neuropathic pain. Specific Aim 3 details a plan to identify
and pursue a neuroscience focused postdoctoral fellowship following the completion of the dissertation work
described in Specific Aim 2. The overarching goals of this study are to increase our understanding of how nerve
injury increases the excitability of Y1-IN subpopulations, and provide rationale for targeting spinal Y1-INs as a
novel approach to treat neuropathic pain.
项目摘要
慢性疼痛状况通过降低患者的生活质量,给患者、他们的家人和社会带来了沉重的负担
生命和创造巨大的财务后果,每年为美国带来总计超过6300亿美元的
仅美国一国。神经性疼痛是一种由病变或疾病引起的使人衰弱的慢性疼痛。
影响到体感系统。神经病理性疼痛影响7-8%的普通人群,但并不严重
对包括阿片类药物在内的止痛药的反应,因此,治疗的替代疗法迫切需要
需要的。然而,神经病理性疼痛发生和维持的潜在机制是
人们对此知之甚少。据推测,神经病理性疼痛是由于脊髓背角抑制丧失所致。
和/或允许传播低阈值无害输入的背角激励中的增益
被视为痛苦的。神经损伤究竟是如何破坏这种平衡以产生净伤害感受性音调的,
然而,目前仍不清楚。具体目标1描述了我们实验室内有希望的初步数据
谷氨酸能背角中间神经元表达神经肽Y(NPY)Y1受体
神经病理性疼痛的发展和维持。第一,选择性消融神经肽Y1受体-
鞘内注射NPY-Saporin表达中间神经元(Y1-ins)可减少大鼠行为体征的发生
神经性疼痛。其次,鞘内药理学和椎管内化学发生技术表明,Y1-
INS对神经病理性疼痛的行为表现既是必要的也是充分的。最后,两人都是单身
细胞RNA测序和荧光原位杂交数据表明,Y1-INS分离为三个不同的
背角中间神经元亚群。总之,这些观察结果构成了我的中央
假设神经损伤增加Y1-INS的兴奋性,这使得一个或多个亚群
Y1-INS对于神经病理性疼痛的行为症状是必要的。《特定目标2》将探讨这一假说。
通过椎管内药理学、行为测试、体内无线光遗传学、交叉CRE-lox
转基因和膜片钳电生理学。这些方法将一起测试哪个Y1-In亚群(S)
是神经病理性疼痛的行为体征所必需的。此外,这些方法将评估前
或突触后对Y1-INS的兴奋和抑制活性揭示神经损伤后的机制变化
这可能会导致神经病理性疼痛的发展。具体目标3详细说明了一项确定
在完成论文工作后,继续以神经科学为重点的博士后研究
在具体目标中描述2.这项研究的首要目标是增加我们对神经
损伤增加了Y1-IN亚群的兴奋性,并为以脊髓Y1-IN为靶点提供了理论基础
治疗神经病理性疼痛的新方法。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Emerging Translational Potential of MNK Inhibitors for the Treatment of Chronic Pain.
MNK 抑制剂治疗慢性疼痛的新兴转化潜力。
- DOI:10.1016/j.neuroscience.2023.02.009
- 发表时间:2023
- 期刊:
- 影响因子:3.3
- 作者:Nelson,TylerS;Khanna,Rajesh
- 通讯作者:Khanna,Rajesh
The spino-parabrachio-amygdaloid pathway is critical for the manifestation of chronic pain.
脊髓-旁臂肌-杏仁通路对于慢性疼痛的表现至关重要。
- DOI:10.1038/s41386-023-01745-7
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Nelson,TylerS;Allen,HeatherN
- 通讯作者:Allen,HeatherN
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tyler Scott Nelson其他文献
Tyler Scott Nelson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tyler Scott Nelson', 18)}}的其他基金
Targeting Spinal Neuropeptide Y1 Receptor-expressing Neurons for the Control of Neuropathic Pain
靶向表达脊髓神经肽 Y1 受体的神经元来控制神经性疼痛
- 批准号:
10687806 - 财政年份:2021
- 资助金额:
$ 8.64万 - 项目类别:
Targeting Spinal Neuropeptide Y1 Receptor-expressing Neurons for the Control of Neuropathic Pain
靶向表达脊髓神经肽 Y1 受体的神经元来控制神经性疼痛
- 批准号:
10319216 - 财政年份:2021
- 资助金额:
$ 8.64万 - 项目类别:














{{item.name}}会员




